ASMI
Positive results for S3 ad push
New research by UTS involving more than 2000 participants has shown S3 advertising is unlikely to lead to inappropriate use of medicine The Australian Self Medication Industry (ASMI) commissioned the …
NSAIDs still suitable, says ASMI
NSAIDs such as ibuprofen and diclofenac remain a suitable choice for relief of acute pain for most people, says ASMI ASMI was responding to reporting of an Australian study at …
Medicines group calls for downscheduling
A widespread switch from prescription to OTC medicines is best for the healthcare system and consumers, says ASMI in its 2017 pre-budget submission The Australian Self-Medication Industry, which released its …
Targeted codeine measures should have been tried first
ASMI has expressed disappointment that more targeted measures for codeine-containing medicines currently available OTC were not tried before the TGA decided to upschedule the preparations. The decision comes despite the …
Upscheduling codeine disregards pharmacist expertise: ASMI
The Australian Self Medication Industry has restated its support for retaining the current status of over-the-counter codeine-containing analgesics. The statement follows several mainstream media reports over the last 24 hours, …
Switch hitters recognised
Some of the leading OTC sales and marketing campaigns were recognised at the Australian Self Medication Industry (ASMI) Diamond Awards dinner. Held in Sydney late last week, three categories of …
Keeping S3 ad restrictions keeps consumers in the dark: ASMI
ASMI is disappointed with the Government’s decision to retain S3 advertising restrictions and to replace the current mandatory advertising pre-approvals system with a self-regulatory system, it says. In welcoming the …
Non-prescription labelling reformed
The Australian Self Medication Industry has welcomed publication of the new Therapeutic Goods Order, marking the conclusion of the TGA’s medicines labelling review “We greatly appreciate the TGA’s inclusive, collaborative …
Ley to headline ASMI conference
Federal Health Minister, Sussan Ley, is expected to open the 2016 conference of the Australian Self Medication Industry on 27 October 2016, ASMI said today. Delegates will hear about new …
Call for research into CMs
Complementary medicines research is needed to build the evidence base about the safety, efficacy and public health benefits of these products and better inform health care policy decisions, ASMI has …
Four Corners: Australian CM experience is different, say stakeholders
Industry stakeholders have expressed disappointment with last night’s Four Corners program, Supplements and Safety, highlighting the difference between the US and Australian complementary medicines landscapes. Complementary Medicines Australia says it …
Direct-to-consumer S3 advertising: it’s time
It’s time to get serious about direct-to-consumer advertising of S3 products, ortherwise known as Pharmacist Only medications, says Dr Deon Schoombie.